ArticleRheumatology international2015

Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers.

Piotr Adrian Klimiuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.